Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Crexendo (CXDO) EBITDA (2016 - 2026)

Crexendo filings provide 15 years of EBITDA readings, the most recent being $1.1 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 80.83% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.7 million, a 157.13% increase, with the full-year FY2025 number at $4.7 million, up 157.13% from a year prior.
  • EBITDA hit $1.1 million in Q4 2025 for Crexendo, down from $1.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $1.3 million in Q3 2025 to a low of -$34.6 million in Q4 2022.
  • Median EBITDA over the past 5 years was $249500.0 (2023), compared with a mean of -$1.6 million.
  • Biggest five-year swings in EBITDA: crashed 4241.66% in 2022 and later surged 1547.37% in 2024.
  • Crexendo's EBITDA stood at -$797000.0 in 2021, then crashed by 4241.66% to -$34.6 million in 2022, then surged by 100.11% to $38000.0 in 2023, then surged by 1547.37% to $626000.0 in 2024, then soared by 80.83% to $1.1 million in 2025.
  • The last three reported values for EBITDA were $1.1 million (Q4 2025), $1.3 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.